0000899243-22-034950.txt : 20221103
0000899243-22-034950.hdr.sgml : 20221103
20221103173014
ACCESSION NUMBER: 0000899243-22-034950
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221101
FILED AS OF DATE: 20221103
DATE AS OF CHANGE: 20221103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shetty Reshma P.
CENTRAL INDEX KEY: 0001873523
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40097
FILM NUMBER: 221359306
MAIL ADDRESS:
STREET 1: C/O SOARING EAGLE ACQUISITION CORP.
STREET 2: 955 FIFTH AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10075
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ginkgo Bioworks Holdings, Inc.
CENTRAL INDEX KEY: 0001830214
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 872652913
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 27 DRYDOCK AVENUE
STREET 2: 8TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: (877) 442-5362
MAIL ADDRESS:
STREET 1: 27 DRYDOCK AVENUE
STREET 2: 8TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02210
FORMER COMPANY:
FORMER CONFORMED NAME: Soaring Eagle Acquisition Corp.
DATE OF NAME CHANGE: 20210210
FORMER COMPANY:
FORMER CONFORMED NAME: Spinning Eagle Acquisition Corp.
DATE OF NAME CHANGE: 20201027
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-11-01
0
0001830214
Ginkgo Bioworks Holdings, Inc.
DNA
0001873523
Shetty Reshma P.
C/O GINKGO BIOWORKS HOLDINGS, INC.
27 DRYDOCK AVENUE
BOSTON
MA
02210
1
1
1
0
See remarks
Class A Common Stock
2022-11-01
4
S
0
196307
2.768
D
22780078
D
Class A Common Stock
2022-11-01
4
S
0
196308
2.768
D
22780078
I
By Spouse
Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction.
President, COO & Founder
/s/ Karen Tepichin, Attorney-in-Fact
2022-11-03